Camden Property Trust
CPT
NYSE·Real Estate·REIT - Residential·Mkt cap $10.6B
$105.69
▲ +0.09%
P/E
35.11
Mkt Cap
$10.6B
52-Wk Range
$96.53–$119.81
52-Week Range
$96.53 - $119.81
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 4.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Extensive geographic portfolio diversification
- Strong workplace culture and employee retention
- Experienced management team
- Consistent track record of property performance
Bear Case
2 risks
- Low volatility (beta 0.8).
- High premium - requires strong execution
Growth
Strong growth ahead
Ongoing urban and suburban housing demand
Value
High premium - requires strong execution
Momentum
Weak
-6.4% over 3m
Quality
Stable
Solid business
Dividend
Solid
3.99% yield
Smart-money signal
Who's buying CPT right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
JUL 30, 2026
Reported EPS of $0.18 vs $0.31 consensus (-41.5% surprise). Revenue of $392.9M vs $392.9M expected (+0.0%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-41.5%
Revenue trend · last 8Q
—
-0%
+2%
+2%
+2%
+1%
+0%
-100%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$387.2M
$386.3M
$390.6M
$396.5M
$395.7M
$390.8M
$390.9M
$0
Margins · last 8Q
Gross
—
Operating
—
Profit
—
Wall Street consensus
9 analysts · 11% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
11%
Hold
78%
Sell
11%
Median Price Target
—
Latest: Wells Fargo · Jul 22, 2026
vs Industry
How CPT stacks vs REIT - Residential
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related